Commentary on the study of Laatsch et al. "Insulin stimulates hepatic low density lipoprotein receptor-related protein 1 (LRP1) to increase postprandial lipoprotein clearance"

Atherosclerosis

Volumn 204, Issue 1, 2009, Pages 112-113

  Santos, Raul D ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CHYLOMICRON REMNANT; GLUCOSE; LEPTIN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; RECOMBINANT HUMAN INSULIN;

CELL MEMBRANE; CELL VACUOLE; INSULIN RESISTANCE; LETTER; LIPOPROTEIN METABOLISM; LIVER CELL; LIVER CLEARANCE; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; STIMULATION; WILD TYPE;

ANIMALS; CARDIOVASCULAR DISEASES; CHYLOMICRON REMNANTS; DISEASE MODELS, ANIMAL; HEPATOCYTES; HUMANS; HYPERLIPIDEMIAS; INSULIN; INSULIN RESISTANCE; LDL-RECEPTOR RELATED PROTEIN 1; LIGANDS; LIPOPROTEINS; POSTPRANDIAL PERIOD; RECOMBINANT PROTEINS;

EID: 67349090602     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2008.10.018     Document Type: Letter

References (22)

1. Razani B., Chakravarthy M.V., and Semenkovich C.F. Insulin resistance and atherosclerosis. Endocrinol Metab Clin North Am 37 (2008) 603-621
2. Annuzzi G., De Natale C., Iovine C., et al. Insulin resistance is independently associated with postprandial alterations of triglyceride-rich lipoproteins in type 2 diabetes mellitus. Arterioscler Thromb Vasc Biol 24 (2004) 2397-2402
3. Hsieh J., Hayashi A.A., Webb J., and Adeli K. Postprandial dyslipidemia in insulin resistance: mechanisms and role of intestinal insulin sensititvity. Atherosclerosis 9 Suppl (2008) 7-13
4. Groot P.H., van Stiphout W.A., Kraus X.H., et al. Postprandial lipoprotein metabolism in normolipidemic men with and without coronary artery disease. Arterioscler Thromb 11 (1991) 653-662
5. Kugiyama K., Doi H., Takazoe K., et al. Remnant lipoprotein levels in fasting serum predict coronary events in patients with coronary artery disease. Circulation 99 (1999) 2858-2860
6. Sposito A.C., Lemos P.A., Santos R.D., et al. Impaired intravascular triglyceride lipolysis constitutes a marker of clinical outcome in patients with stable angina undergoing secondary prevention treatment: a long-term follow-up study. J Am Coll Cardiol 43 (2004) 2225-2232
7. Nordestgaard B.G., Benn M., Schnohr P., and Tybjaerg-Hansen A. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA 298 (2007) 299-308
8. Mamo J.C.L., Proctor S.D., and Smith D. Retention of chylomicron remnants by arterial tissue: importance of an efficient clearance mechanism from plasma. Atherosclerosis 141 (1998) S63-S69
9. Cohn J.S. Postprandial lipemia and remnant lipoproteins. Clin Lab Med 26 (2006) 773-786
10. Havel R.J., and Hamilton R.L. Hepatic catabolism of remnant lipoproteins: where the action is. Arterioscler Thromb Vasc Biol 24 (2004) 213-215
11. Out R., Kruijt J.K., Rensen P.C., et al. Scavenger receptor BI plays a role in facilitating chylomicron metabolism. J Biol Chem 279 (2004) 18401-18406
12. Hogue J.C., Lamarche B., Tremblay A.J., Bergeron J., Gagné C., and Couture P. Evidence of increased secretion of apolipoprotein B-48-containing lipoproteins in subjects with type 2 diabetes. J Lipid Res 48 (2007) 1336-1342
13. Descamps O., Bilheimer D., and Herz J. Insulin stimulates receptor-mediated uptake of apoE-enriched lipoproteins and activated alpha 2-macroglobulin in adipocytes. J Biol Chem 268 (1993) 974-981
14. Laatsch A., Merkel M., Talmud P.J., Grewal T., Beisiegel U., and Heeren J. Insulin stimulates hepatic low density lipoprotein receptor-related protein 1 (LRP1) to increase postprandial lipoprotein clearance. Atherosclerosis August 29 (2008) [Epub ahead of print]
15. Pessin J.E., Thurmond D.C., Elmendorf J.S., Coker K.J., and Okada S. Molecular basis of insulin-stimulated GLUT4 vesicle trafficking. Location! Location! Location!. J Biol Chem 274 (1999) 2593-2596
16. Santos R.D., Sposito A.C., Ventura L.I., Cesar L.A., Ramires J.A., and Maranhão R.C. Effect of pravastatin on plasma removal of a chylomicron-like emulsion in men with coronary artery disease. Am J Cardiol 85 (2000) 1163-1166
17. Santos R.D., Ventura L.I., Spósito A.C., Schreiber R., Ramires J.A., and Maranhão R.C. The effects of gemfibrozil upon the metabolism of chylomicron-like emulsions in patients with endogenous hypertriglyceridemia. Cardiovasc Res 49 (2001) 456-465
18. Hardman A.E. The influence of exercise on postprandial triacylglycerol metabolism. Atherosclerosis 141 Suppl 1 (1998) S93-S100
19. Grosskopf I., Ringel Y., Charach G., et al. Metformin enhances clearance of chylomicrons and chylomicron remnants in nondiabetic mildly overweight glucose-intolerant subjects. Diabetes Care 20 (1997) 1598-1602
20. Lally S., Owens D., and Tomkin G.H. The different effect of pioglitazone as compared to insulin on expression of hepatic and intestinal genes regulating post-prandial lipoproteins in diabetes. Atherosclerosis 193 (2007) 343-351
21. James A.P., Watts G.F., and Mamo J.C. The effect of metformin and rosiglitazone on postprandial lipid metabolism in obese insulin-resistant subjects. Diabetes Obes Metab 7 (2005) 381-389
22. Monami M., Marchionni N., and Mannucci E. Winners and losers at the rosiglitazone gamble A meta-analytical approach at the definition of the cardiovascular risk profile of rosiglitazone. Diabetes Res Clin Pract 82 (2008) 48-57